
Saurabh Chandan
Articles
-
Oct 18, 2024 |
mdpi.com | Dushyant Singh Dahiya |Saurabh Chandan |Manesh Kumar Gangwani |Hassam Ali
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Sep 22, 2024 |
mdpi.com | Saurabh Chandan |Dushyant Singh Dahiya |Ganesh Aswath |Daryl Ramai
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Apr 28, 2024 |
mdpi.com | Dushyant Singh Dahiya |Yash Shah |Hassam Ali |Saurabh Chandan
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
Apr 20, 2024 |
giejournal.org | Ravi Teja Pasam |Saurabh Chandan |Babu Mohan
To the Editor:We congratulate Radadiya et al1Radadiya D. Desai M. Patel H. et al. Analyzing methods for reducing recurrence rates after EMR of large non-pedunculated colorectal polyps: an indirect pairwise comparison. on their recent study comparing various EMR techniques for large nonpedunculated colorectal polyps by using indirect pairwise comparison. However, their study included observational studies and randomized control trials (RCTs), which limits the ability to draw conclusions.
-
Feb 3, 2024 |
giejournal.org | Saurabh Chandan |Daryl Ramai |Daniel Mozell |Antonio Facciorusso
The SpyGlass (Boston Scientific, Marlborough, Mass, USA) single-operator cholangioscopy (SOC) system is generally considered to be safe but adds additional risks to those associated with standard ERCP. We evaluated adverse events (AEs) associated with the SpyGlass system reported in the U.S. Food and Drug Administration Manufacturer and User Facility Device Experience database between January 2016 and August 2023.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →